A prospective study analysing peginterferon beta-1a in the breast milk of lactating patients with multiple sclerosis
Latest Information Update: 21 May 2020
At a glance
- Drugs Peginterferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Pharmacokinetics
Most Recent Events
- 21 May 2020 New trial record
- 01 May 2020 Interim Results (n=6) evaluating peginterferon beta-1a in the breast milk of lactating patients with multiple sclerosis, presented at the 72nd Annual Meeting of the American Academy of Neurology